Well this is either gonna just keep on cratering into oblivion or it's one of those deals where the powers that be are scaring everyone away before a big jump up. And considering I'm down about a buck a share as it is, it's gonna have to be a big jump to make up for this debacle.
The entire market is being driven by panic selling Ebola idiots...but I thank them for the $3.50 shares...wish I had a few hundred grand to dump into the airline stocks that are way oversold.
Agreed. Only people who got in for less than .24 (pre split) would be making a profit by selling (and not much of a profit) so my only conclusion is that these are the same dumb a's who are jumping out of the market all over and into their Ebola proof hazmat suits.
Should easily go over a half million shares traded by the end of the day. Some of the oddest trading I have seen in a long time. Not really buying into the whole shorts thing (just seems like a horrible short target..let alone the fact it's pretty far off the radar). Anyways, you would think that when a stock trades at 8-10 times the normal volume it would either go way up or way down but this seems to have no direction. Weird as hell.
Now I understand...it was a giant head fake by the powers that be. Man I hate how we all can't play by the same rules
13K shares just sold for less than $.25 (pre split price). I really don't get it... Who are you people?
Unless you got in pre-Feb or so you are in at cost above the current share price, so in other words anyone who bought after Feb and is selling now is selling at a loss. I'm finding it hard to believe the shares being sold now are being sold at a profit so it begs the question - #$%$ are people thinking? No bad news, things look promising, so why sell. Oh well, there's things I often don't get - like people freaking out and dumping stocks because I dude in Dallas has Ebola. Trigger happy idiots.
NEW YORK, NEW YORK AND PETACH TIKVAH, ISRAEL , United States, via ETELIGIS INC., 09/24/2014 - - BrainStorm Cell Therapeutics Inc. ( OTCQB: BCLI, BCLID ), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that its shares of common stock have been approved for uplisting to the NASDAQ Capital Market, and hopes to commence trading on the NASDAQ Capital Market when trading begins on September 30, 2014.
Updated Date Old Symbol Old Name New Symbol New Name Comment
16:46 9/16/2014 BCLI Brainstorm Cell Therapeutics Inc. Common Stock BCLID Brainstorm Cell Therapeutics Inc. NEW Common Stock